S&P 500   4,528.01 (-0.18%)
DOW   35,504.76 (-0.29%)
QQQ   374.25 (-0.19%)
AAPL   148.87 (-0.26%)
MSFT   307.66 (+0.08%)
FB   340.41 (-0.11%)
GOOGL   2,836.69 (+0.05%)
TSLA   855.89 (-1.14%)
AMZN   3,413.86 (-0.04%)
NVDA   221.25 (+0.10%)
BABA   177.41 (+0.13%)
NIO   39.45 (-0.83%)
AMD   116.43 (+0.03%)
MU   67.91 (-0.53%)
T   26.20 (+1.12%)
F   16.15 (+0.69%)
ACB   7.62 (-0.52%)
DIS   170.25 (-0.18%)
PFE   42.97 (+0.40%)
BA   216.40 (+0.11%)
AMC   40.88 (+0.00%)
S&P 500   4,528.01 (-0.18%)
DOW   35,504.76 (-0.29%)
QQQ   374.25 (-0.19%)
AAPL   148.87 (-0.26%)
MSFT   307.66 (+0.08%)
FB   340.41 (-0.11%)
GOOGL   2,836.69 (+0.05%)
TSLA   855.89 (-1.14%)
AMZN   3,413.86 (-0.04%)
NVDA   221.25 (+0.10%)
BABA   177.41 (+0.13%)
NIO   39.45 (-0.83%)
AMD   116.43 (+0.03%)
MU   67.91 (-0.53%)
T   26.20 (+1.12%)
F   16.15 (+0.69%)
ACB   7.62 (-0.52%)
DIS   170.25 (-0.18%)
PFE   42.97 (+0.40%)
BA   216.40 (+0.11%)
AMC   40.88 (+0.00%)
S&P 500   4,528.01 (-0.18%)
DOW   35,504.76 (-0.29%)
QQQ   374.25 (-0.19%)
AAPL   148.87 (-0.26%)
MSFT   307.66 (+0.08%)
FB   340.41 (-0.11%)
GOOGL   2,836.69 (+0.05%)
TSLA   855.89 (-1.14%)
AMZN   3,413.86 (-0.04%)
NVDA   221.25 (+0.10%)
BABA   177.41 (+0.13%)
NIO   39.45 (-0.83%)
AMD   116.43 (+0.03%)
MU   67.91 (-0.53%)
T   26.20 (+1.12%)
F   16.15 (+0.69%)
ACB   7.62 (-0.52%)
DIS   170.25 (-0.18%)
PFE   42.97 (+0.40%)
BA   216.40 (+0.11%)
AMC   40.88 (+0.00%)
S&P 500   4,528.01 (-0.18%)
DOW   35,504.76 (-0.29%)
QQQ   374.25 (-0.19%)
AAPL   148.87 (-0.26%)
MSFT   307.66 (+0.08%)
FB   340.41 (-0.11%)
GOOGL   2,836.69 (+0.05%)
TSLA   855.89 (-1.14%)
AMZN   3,413.86 (-0.04%)
NVDA   221.25 (+0.10%)
BABA   177.41 (+0.13%)
NIO   39.45 (-0.83%)
AMD   116.43 (+0.03%)
MU   67.91 (-0.53%)
T   26.20 (+1.12%)
F   16.15 (+0.69%)
ACB   7.62 (-0.52%)
DIS   170.25 (-0.18%)
PFE   42.97 (+0.40%)
BA   216.40 (+0.11%)
AMC   40.88 (+0.00%)
CVE:SCYB

Scythian Biosciences Stock Forecast, Price & News

C$3.49
-0.22 (-5.93 %)
(As of 07/25/2018)
Add
Compare
Today's Range
C$3.46
C$3.77
50-Day Range
C$3.49
C$3.49
52-Week Range
C$1.01
C$8.61
Volume703,164 shs
Average Volume231,491 shs
Market CapitalizationC$102.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SCYB News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.


About Scythian Biosciences

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$102.38 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Scythian Biosciences (CVE:SCYB) Frequently Asked Questions

What stocks does MarketBeat like better than Scythian Biosciences?

Wall Street analysts have given Scythian Biosciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Scythian Biosciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Scythian Biosciences' key executives?

Scythian Biosciences' management team includes the following people:
  • Mr. Rob Reid, CEO & Director
  • Mr. Jonathan James Held, Chief Financial Officer (Age 32)
  • Mr. Maghsoud Dariani, Chief Scientific Officer (Age 65)
  • Prof. Michael Barnes, Chief Medical Officer

What other stocks do shareholders of Scythian Biosciences own?

What is Scythian Biosciences' stock symbol?

Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB."

How do I buy shares of Scythian Biosciences?

Shares of SCYB and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Scythian Biosciences' stock price today?

One share of SCYB stock can currently be purchased for approximately C$3.49.

How much money does Scythian Biosciences make?

Scythian Biosciences has a market capitalization of C$102.38 million.

What is Scythian Biosciences' official website?

The official website for Scythian Biosciences is scythianbio.com.

Where are Scythian Biosciences' headquarters?

Scythian Biosciences is headquartered at 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada.

How can I contact Scythian Biosciences?

Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The company can be reached via phone at +1-416-3669192.


This page was last updated on 10/21/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.